CymitQuimica logo
MAPK

MAPK

Le MAPK sono una famiglia di chinasi proteiche coinvolte in una varietà di processi cellulari, tra cui crescita, proliferazione, differenziazione e risposte allo stress. La via di segnalazione MAPK è composta da diversi livelli, tra cui ERK, JNK e p38 MAPK, ciascuno con ruoli distinti nella funzione cellulare. La disregolazione della segnalazione MAPK è collegata al cancro, alle malattie infiammatorie e ai disturbi metabolici. Presso CymitQuimica, offriamo una vasta gamma di inibitori e attivatori delle MAPK per supportare la tua ricerca in biologia cellulare, trasduzione del segnale e meccanismi delle malattie.

Trovati 894 prodotti di "MAPK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • p38-α MAPK-IN-10

    CAS:
    <p>p38-α MAPK-IN-10 (Compound 6) is an inhibitor of p38α, with an IC50 value of 4 nM.</p>
    Formula:C27H34Cl2N6
    Colore e forma:Solid
    Peso molecolare:513.505
  • Brimarafenib

    CAS:
    Brimarafenib is a selective RAF dimerization inhibitor, which can inhibit BRAF and CRAF, and exhibits inhibitory effects on a variety of RAF mutations.
    Formula:C24H17F3N4O4
    Purezza:98.32%
    Colore e forma:Solid
    Peso molecolare:482.41
  • p38-α MAPK-IN-9

    CAS:
    <p>p38-α MAPK-IN-9 (Compound 25a) is a p38-α MAPK inhibitor with a Ki value of 0.057 nM. It effectively inhibits LPS-induced TNFα production in hPBMC cells, exhibiting an IC50 of 18 nM.</p>
    Formula:C19H20N8O2
    Colore e forma:Solid
    Peso molecolare:392.414
  • Casein kinase 1δ-IN-31

    CAS:
    <p>Casein kinase1δ-IN-31 (Compound 16) is an inhibitor of casein kinase (CK), specifically targeting CK1α, CK1δ, and p38α, with IC50 values of 196 nM, 17 nM, and 18 nM, respectively. Additionally, Casein kinase1δ-IN-31 inhibits Double Homeobox 4 (DUX4) with an IC50 of 1200 nM.</p>
    Formula:C17H13FN4
    Colore e forma:Solid
    Peso molecolare:292.31
  • pan-KRAS-IN-17

    CAS:
    <p>pan-KRAS-IN-17 (Example 34) is an inhibitor that targets multiple forms of the KRAS protein.</p>
    Formula:C34H33F3N5O8P
    Colore e forma:Solid
    Peso molecolare:727.623
  • JNK-1-IN-4

    CAS:
    <p>JNK-1-IN-4 (Compound E1) is an inhibitor of JNK, targeting JNK-1, JNK-2, and JNK-3 with IC50 values of 2.7, 19.0, and 9.0 nM, respectively. This compound inhibits the phosphorylation of c-Jun and reduces the expression of TGF-β1-induced EMT markers (such as fibronectin and α-SMA). JNK-1-IN-4 exhibits favorable pharmacokinetic properties with a bioavailability of 69%. Additionally, it demonstrates antifibrotic effects in a Bleomycin-induced mouse model of idiopathic pulmonary fibrosis.</p>
    Formula:C22H25BrN6O3
    Colore e forma:Solid
    Peso molecolare:501.38
  • AM-001

    CAS:
    AM-001 is a non-competitive inhibitor of Epac1, preventing the activation of its downstream effector Rap1 in cultured cells. This compound is utilized in research related to cardiac diseases.
    Formula:C24H16FN3OS2
    Colore e forma:Solid
    Peso molecolare:445.53
  • J-104871

    CAS:
    <p>J-104871 (UNII-6137X5QNJF) is an FTase inhibitor that inhibits tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.</p>
    Formula:C38H32N2O12
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:708.67
  • KRAS inhibitor-37

    CAS:
    KRAS inhibitor-37 (compound 2) is a potent inhibitor of KRAS, exhibiting low dissociation constants (KD) with various KRAS mutations: wild type (0.004 nM), G12D (0.041 nM), G12C (0.019 nM), and G12V (0.144 nM). This compound effectively inhibits cell proliferation, demonstrating half-maximal inhibitory concentrations (IC50) ranging from <2 nM to 14 nM in H358, SW620, and PANC08.13 cell lines. KRAS inhibitor-37 holds potential for cancer research applications.
    Formula:C32H33ClFN7O3
    Colore e forma:Solid
    Peso molecolare:618.10
  • KRAS G12C inhibitor 20

    CAS:
    <p>KRAS G12C inhibitor 20 is a KRAS G12C inhibitor.</p>
    Formula:C33H37ClFN7O3
    Colore e forma:Solid
    Peso molecolare:634.14
  • EBI-1051

    CAS:
    EBI-1051 is a highly potent and orally efficacious inhibitor of MEK (IC50: 3.9 nM).
    Formula:C18H15F2IN2O5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:504.22
  • KRAS G12C inhibitor 56

    CAS:
    KRAS G12C inhibitor 56, a powerful inhibitor of SOS1 with an inhibitory concentration (IC50) of 1.6 nM, holds promise for use in cancer research.
    Formula:C32H39N7O4S
    Colore e forma:Solid
    Peso molecolare:617.76
  • p38α MAPK/CK1δ inhibitor-1

    CAS:
    <p>p38αMAPK/CK1δ inhibitor-1 (Compound 3) exhibits inhibitory activity against p38αMAPK and CK1δ, with IC50 values of 0.185 µM and 0.089 µM, respectively.</p>
    Formula:C24H17FN6O2
    Colore e forma:Solid
    Peso molecolare:440.429
  • G-479

    CAS:
    <p>G-479, a potent MEK inhibitor and improved analogue of GDC-0623, has distributed polarity enhancing bioactivity.</p>
    Formula:C16H15FIN5O4
    Colore e forma:Solid
    Peso molecolare:487.22
  • NHTD

    CAS:
    NHTD, a KRAS-PDEδ inhibitor, exerts its function by targeting the isoprenyl binding pocket of PDEδ, which alters the cellular localization of KRAS. This modification restricts the proliferation of cancer cells with KRAS mutations and induces cell apoptosis (Apoptosis). NHTD is utilized in the study of KRAS-driven non-small cell lung cancer (NSCLC).
    Formula:C24H26N2O5
    Colore e forma:Solid
    Peso molecolare:422.47
  • Anti-osteoporosis agent-11

    CAS:
    <p>Anti-osteoporosis agent-11 (compound 3k) is an anti-osteoporosis compound targeting osteoclasts. It exhibits its most prominent effect by inhibiting osteoclast differentiation, with an IC50 value of 0.36 μM. Additionally, Anti-osteoporosis agent-11 suppresses osteoclast formation, bone resorption, and the expression of osteoclast-specific genes by blocking the RANKL-induced mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways.</p>
    Formula:C23H17NO2Se2
    Colore e forma:Solid
    Peso molecolare:497.31
  • HPK1 ligand-Linker Conjugate 1

    CAS:
    HPK1 ligand-Linker Conjugate 1 is a synthetic target protein ligand-linker compound used in the synthesis of PROTACs, such as PROTACHPK1 Degrader-5. PROTACHPK1 Degrader-5 is a potent and orally active HPK1 PROTAC degrader with anti-tumor activity.
    Formula:C19H21N3O7S
    Colore e forma:Solid
    Peso molecolare:435.45
  • ADT-1004

    CAS:
    ADT-1004 is an inhibitor of RAS. It can be used for research involving Ras-mediated diseases.
    Formula:C33H36FN3O6
    Colore e forma:Soild
    Peso molecolare:589.65
  • ABS-752

    CAS:
    ABS-752 is an effective and orally active molecular glue degrader targeting GSPT1 and NEK7. It exhibits cytotoxic properties and reduces the protein expression of GSPT1, SALL4, and NEK7. ABS-752 possesses anticancer activity and shows potential for research in hepatocellular carcinoma.
    Formula:C14H14FN3O3
    Colore e forma:Solid
    Peso molecolare:291.28
  • MNK1 ligand 1

    CAS:
    MNK1ligand 1 (Compound 5) is an MNK1 ligand used in the synthesis of PROTACMNK1 degrader-1.
    Formula:C15H17N3OS
    Colore e forma:Solid
    Peso molecolare:287.38